Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 4
2007 8
2008 5
2009 5
2010 3
2011 7
2012 8
2013 15
2014 10
2015 7
2016 15
2017 9
2018 11
2019 8
2020 21
2021 19
2022 16
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Pasquier D, Bidaut L, Oprea-Lager DE, deSouza NM, Krug D, Collette L, Kunz W, Belkacemi Y, Bau MG, Caramella C, De Geus-Oei LF, De Caluwé A, Deroose C, Gheysens O, Herrmann K, Kindts I, Kontos M, Kümmel S, Linderholm B, Lopci E, Meattini I, Smeets A, Kaidar-Person O, Poortmans P, Tsoutsou P, Hajjaji N, Russell N, Senkus E, Talbot JN, Umutlu L, Vandecaveye V, Verhoeff JJC, van Oordt WMH, Zacho HD, Cardoso F, Fournier L, Van Duijnhoven F, Lecouvet FE. Pasquier D, et al. Among authors: deroose c. Lancet Oncol. 2023 Aug;24(8):e331-e343. doi: 10.1016/S1470-2045(23)00286-3. Lancet Oncol. 2023. PMID: 37541279 Review.
Nuclear medicine in precision oncology: a foreword.
de Geus-Oei LF, Deroose CM. de Geus-Oei LF, et al. Among authors: deroose cm. Q J Nucl Med Mol Imaging. 2020 Sep;64(3):231-233. doi: 10.23736/S1824-4785.20.03262-8. Epub 2020 Apr 28. Q J Nucl Med Mol Imaging. 2020. PMID: 32343513 Free article. No abstract available.
PET imaging in adaptive radiotherapy of gastrointestinal tumors.
Bulens P, Thomas M, Deroose CM, Haustermans K. Bulens P, et al. Among authors: deroose cm. Q J Nucl Med Mol Imaging. 2018 Dec;62(4):385-403. doi: 10.23736/S1824-4785.18.03081-9. Epub 2018 Jun 4. Q J Nucl Med Mol Imaging. 2018. PMID: 29869484 Free article. Review.
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.
Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O'Toole D, Sundin A, Prasad V. Hicks RJ, et al. Among authors: deroose cm. J Neuroendocrinol. 2022 Mar;34(3):e13040. doi: 10.1111/jne.13040. Epub 2021 Oct 20. J Neuroendocrinol. 2022. PMID: 34668262 Free PMC article. Review.
Impact of the COVID-19 crisis on imaging in oncological trials.
Deroose CM, Lecouvet FE, Collette L, Oprea-Lager DE, Kunz WG, Bidaut L, Verhoeff JJC, Caramella C, Lopci E, Tombal B, de Geus-Oei LF, Fournier L, Smits M, deSouza NM. Deroose CM, et al. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2054-2058. doi: 10.1007/s00259-020-04910-y. Eur J Nucl Med Mol Imaging. 2020. PMID: 32533240 Free PMC article. No abstract available.
Radioligand therapies in cancer: mapping the educational landscape in Europe.
Bugani V, Battistelli L, Sansovini M, Monti M, Paganelli G, Gich I, Flotats A, Erba PA, Blay JY, la Fougère C, Van Poppel H, Charalambous A, Herrmann K, Giordano A, Györke T, Deroose C, Matteucci F, Carrió I. Bugani V, et al. Among authors: deroose c. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2692-2698. doi: 10.1007/s00259-023-06217-0. Epub 2023 Apr 14. Eur J Nucl Med Mol Imaging. 2023. PMID: 37058168 Free PMC article.
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.
Ahenkorah S, Cassells I, Deroose CM, Cardinaels T, Burgoyne AR, Bormans G, Ooms M, Cleeren F. Ahenkorah S, et al. Among authors: deroose cm. Pharmaceutics. 2021 Apr 21;13(5):599. doi: 10.3390/pharmaceutics13050599. Pharmaceutics. 2021. PMID: 33919391 Free PMC article. Review.
18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.
Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Boeckxstaens L, Dekervel J, Vandamme T, Lybaert W, den Broeck BV, Laenen A, Clement PM, Geboes K, Cutsem EV, Stroobants S, Verslype C, Bormans G, Deroose CM. Pauwels E, et al. Among authors: deroose cm. J Nucl Med. 2023 Apr;64(4):632-638. doi: 10.2967/jnumed.122.264563. Epub 2022 Oct 20. J Nucl Med. 2023. PMID: 36265911 Free article.
172 results